VioQuest Pharmaceuticals, Inc.
VOQP
$0.00
$0.000.00%
| 06/30/2008 | 03/31/2008 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.63% | 141.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -38.44% | 12.77% | |||
| Operating Income | 38.44% | -12.77% | |||
| Income Before Tax | 63.30% | 5.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 63.30% | -2.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 63.30% | -2.04% | |||
| EBIT | 38.44% | -12.77% | |||
| EBITDA | 38.50% | -12.79% | |||
| EPS Basic | 40.30% | -1.34% | |||
| Normalized Basic EPS | 63.29% | -45.97% | |||
| EPS Diluted | 40.30% | -1.34% | |||
| Normalized Diluted EPS | 63.29% | -45.97% | |||
| Average Basic Shares Outstanding | -0.01% | 0.69% | |||
| Average Diluted Shares Outstanding | -0.01% | 0.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
